Insider · CIK 0001982985
Arjun JJ Desai
Files at CLNN (Clene Inc.), TLSI (TriSalus Life Sciences, Inc.). First filing Dec 12, 2024, latest Dec 12, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TLSI: TriSalus Life Sciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | TLSIsell TriSalus Life Sciences, Inc. | $111k 30,000 shares | -11% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | CLNN Clene Inc. | AGrant or award stock optionderivative | +4,278 | $0.00 | $0 | 4,278 | Aug 15, 2025 |
| Jun 12, 2025 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 65,000 | Jun 27, 2025 |
| May 22, 2025 | CLNN Clene Inc. | AGrant or award Stock Options (Right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | May 23, 2025 |
| May 22, 2025 | CLNN Clene Inc. | AGrant or award Stock Options (Right to buy)derivative | +6,021 | $0.00 | $0 | 6,021 | May 23, 2025 |
| Feb 27, 2025 | CLNN Clene Inc. | AGrant or award Stock Options (Right to buy)derivative | +3,319 | $0.00 | $0 | 3,319 | Feb 28, 2025 |
| Dec 10, 2024 | TLSI TriSalus Life Sciences, Inc. | SOpen-market sale Common Stock | -30,000 | $3.69 | $111k | 247,127 | Dec 12, 2024 |
| Dec 6, 2024 | CLNN Clene Inc. | AGrant or award Stock Options (Right to buy)derivative | +3,280 | $0.00 | $0 | 3,280 | Dec 9, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.